3/24
09:50 am
caba
Cabaletta Bio (CABA) had its price target lowered by Morgan Stanley from $14.00 to $13.00. They now have an "overweight" rating on the stock.
Low
Report
Cabaletta Bio (CABA) had its price target lowered by Morgan Stanley from $14.00 to $13.00. They now have an "overweight" rating on the stock.
3/24
09:50 am
caba
Cabaletta Bio (CABA) had its price target raised by Guggenheim from $15.00 to $16.00. They now have a "buy" rating on the stock.
Low
Report
Cabaletta Bio (CABA) had its price target raised by Guggenheim from $15.00 to $16.00. They now have a "buy" rating on the stock.
3/23
07:40 am
caba
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/23
07:30 am
caba
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Medium
Report
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
3/7
06:05 am
caba
Cabaletta Bio Highlights Pivotal Myositis Trial, No-Preconditioning CAR-T Push at TD Cowen Conference [Yahoo! Finance]
Medium
Report
Cabaletta Bio Highlights Pivotal Myositis Trial, No-Preconditioning CAR-T Push at TD Cowen Conference [Yahoo! Finance]
2/24
08:33 am
caba
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
High
Report
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/24
08:00 am
caba
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
High
Report
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
2/18
08:48 am
caba
Here's Why Jacob Funds Established a Position in Cabaletta Bio (CABA) [Yahoo! Finance]
Medium
Report
Here's Why Jacob Funds Established a Position in Cabaletta Bio (CABA) [Yahoo! Finance]
2/5
09:27 am
caba
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
Medium
Report
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
2/5
08:00 am
caba
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Medium
Report
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
1/30
07:12 pm
caba
What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
Medium
Report
What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
1/27
11:07 am
caba
Cabaletta Bio: Do You Buy With The Insiders? [Seeking Alpha]
Low
Report
Cabaletta Bio: Do You Buy With The Insiders? [Seeking Alpha]
1/12
08:27 am
caba
Cabaletta Bio Announces 2026 Strategic Priorities [Yahoo! Finance]
Medium
Report
Cabaletta Bio Announces 2026 Strategic Priorities [Yahoo! Finance]
1/12
08:00 am
caba
Cabaletta Bio Announces 2026 Strategic Priorities
Medium
Report
Cabaletta Bio Announces 2026 Strategic Priorities
1/12
07:30 am
caba
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms
Medium
Report
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms